{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:35:20Z","timestamp":1794353720372,"version":"4.9.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41401-026-01821-w","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:03:16Z","timestamp":1779246196000},"page":"2619-2637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["METTL16 S-glutathionylation-triggered RNA m6A modification of IGF2BP3 inhibits CFTR expression and promotes chemoresistance in colorectal cancer"],"prefix":"10.1038","volume":"47","author":[{"given":"Lu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ju","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-miao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-min","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-gang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-wan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-kai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lue","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-ping","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-guo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-hua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"1821_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1821_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330\u20138.","journal-title":"Nat Rev Cancer"},{"key":"1821_CR3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13:714\u201326.","journal-title":"Nat Rev Cancer"},{"key":"1821_CR4","doi-asserted-by":"publisher","first-page":"7893","DOI":"10.1002\/anie.201713188","volume":"57","author":"C Dal Magro","year":"2018","unstructured":"Dal Magro C, Keller P, Kotter A, Werner S, Duarte V, Marchand V, et al. A vastly increased chemical variety of RNA modifications containing a thioacetal structure. Angew Chem Int Ed Engl. 2018;57:7893\u20137.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1821_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm3785","volume":"15","author":"KD Meyer","year":"2014","unstructured":"Meyer KD, Jaffrey SR. The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014;15:313\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1821_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19:88.","journal-title":"Mol Cancer"},{"key":"1821_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"1821_CR8","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, et al. Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82:1660\u201377.","journal-title":"Mol Cell"},{"key":"1821_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02013-y","volume":"23","author":"D Wen","year":"2024","unstructured":"Wen D, Xiao H, Gao Y, Zeng H, Deng J. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2. Mol Cancer. 2024;23:116.","journal-title":"Mol Cancer"},{"key":"1821_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100930","volume":"67","author":"X Li","year":"2023","unstructured":"Li X, Ma Y, Wu J, Ni M, Chen A, Zhou Y, et al. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells. Drug Resist Updat. 2023;67:100930.","journal-title":"Drug Resist Updat"},{"key":"1821_CR11","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1210\/jc.2002-021353","volume":"88","author":"H Ishibashi","year":"2003","unstructured":"Ishibashi H, Suzuki T, Suzuki S, Moriya T, Kaneko C, Takizawa T, et al. Sex steroid hormone receptors in human thymoma. J Clin Endocrinol Metab. 2003;88:2309\u201317.","journal-title":"J Clin Endocrinol Metab"},{"key":"1821_CR12","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2018.03.065","volume":"173","author":"L Dai","year":"2018","unstructured":"Dai L, Zhao T, Bisteau X, Sun W, Prabhu N, Lim YT, et al. Modulation of protein-interaction states through the cell cycle. Cell. 2018;173:1481\u201394.","journal-title":"Cell"},{"key":"1821_CR13","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1074\/mcp.RA118.000752","volume":"17","author":"Q Li","year":"2018","unstructured":"Li Q, Cao L, Tian Y, Zhang P, Ding C, Lu W, et al. Butyrate suppresses the proliferation of colorectal cancer cells via targeting pyruvate kinase M2 and metabolic reprogramming. Mol Cell Proteom. 2018;17:1531\u201345.","journal-title":"Mol Cell Proteom"},{"key":"1821_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.freeradbiomed.2018.07.025","volume":"129","author":"X Li","year":"2018","unstructured":"Li X, Wu J, Zhang X, Chen W. Glutathione reductase-mediated thiol oxidative stress suppresses metastasis of murine melanoma cells. Free Radic Biol Med. 2018;129:256\u201367.","journal-title":"Free Radic Biol Med"},{"key":"1821_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwae039","volume":"11","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhang H, Zhong K, Tao L, Lin Y, Xie G, et al. N6-methyladenosine facilitates mitochondrial fusion of colorectal cancer cells via induction of GSH synthesis and stabilization of OPA1 mRNA. Natl Sci Rev. 2024;11:nwae039.","journal-title":"Natl Sci Rev"},{"key":"1821_CR16","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1093\/nar\/gkab415","volume":"49","author":"F Yu","year":"2021","unstructured":"Yu F, Wei J, Cui X, Yu C, Ni W, Bungert J, et al. Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response. Nucleic Acids Res. 2021;49:5779\u201397.","journal-title":"Nucleic Acids Res"},{"key":"1821_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28:616\u201324.","journal-title":"Cell Res"},{"key":"1821_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41556-021-00835-2","volume":"24","author":"R Su","year":"2022","unstructured":"Su R, Dong L, Li Y, Gao M, He PC, Liu W, et al. METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis. Nat Cell Biol. 2022;24:205\u201316.","journal-title":"Nat Cell Biol"},{"key":"1821_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 2014;505:117\u201320.","journal-title":"Nature"},{"key":"1821_CR20","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254\u201370.","journal-title":"Hepatology"},{"key":"1821_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, et al. Nuclear m6A reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016;61:507\u201319.","journal-title":"Mol Cell"},{"key":"1821_CR22","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.7150\/thno.71872","volume":"12","author":"B Tan","year":"2022","unstructured":"Tan B, Zhou K, Liu W, Prince E, Qing Y, Li Y, et al. RNA N6-methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer. Theranostics. 2022;12:5727\u201343.","journal-title":"Theranostics"},{"key":"1821_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/mutage\/ger075","volume":"27","author":"I Hlavata","year":"2012","unstructured":"Hlavata I, Mohelnikova-Duchonova B, Vaclavikova R, Liska V, Pitule P, Novak P, et al. The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis. 2012;27:187\u201396.","journal-title":"Mutagenesis"},{"key":"1821_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154299","volume":"104","author":"Y Cui","year":"2022","unstructured":"Cui Y, Wu Y, Wang C, Wang Z, Li Y, Jiang Z, et al. Isoliquiritigenin inhibits non-small cell lung cancer progression via m6A\/IGF2BP3-dependent TWIST1 mRNA stabilization. Phytomedicine. 2022;104:154299.","journal-title":"Phytomedicine"},{"key":"1821_CR25","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1080\/14786419.2017.1366478","volume":"32","author":"YM Shaalan","year":"2018","unstructured":"Shaalan YM, Handoussa H, Youness RA, Assal RA, El-Khatib AH, Linscheid MW, et al. Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma. Nat Prod Res. 2018;32:2217\u201320.","journal-title":"Nat Prod Res"},{"key":"1821_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118413","volume":"260","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Liu X, Yu M, Xu M, Xiao Y, Ma W, et al. Berberine inhibits proliferation and induces G0\/G1 phase arrest in colorectal cancer cells by downregulating IGF2BP3. Life Sci. 2020;260:118413.","journal-title":"Life Sci"},{"key":"1821_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101086","volume":"22","author":"CC Winterbourn","year":"2019","unstructured":"Winterbourn CC. Regulation of intracellular glutathione. Redox Biol. 2019;22:101086.","journal-title":"Redox Biol"},{"key":"1821_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101472","volume":"32","author":"RJ Mailloux","year":"2020","unstructured":"Mailloux RJ. Protein S-glutathionylation reactions as a global inhibitor of cell metabolism for the desensitization of hydrogen peroxide signals. Redox Biol. 2020;32:101472.","journal-title":"Redox Biol"},{"key":"1821_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.freeradbiomed.2020.09.013","volume":"160","author":"J Zhang","year":"2020","unstructured":"Zhang J, Ye ZW, Chen W, Culpepper J, Jiang H, Ball LE, et al. Altered redox regulation and S-glutathionylation of BiP contribute to bortezomib resistance in multiple myeloma. Free Radic Biol Med. 2020;160:755\u201367.","journal-title":"Free Radic Biol Med"},{"key":"1821_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","volume":"6","author":"Q Li","year":"2021","unstructured":"Li Q, Ni Y, Zhang L, Jiang R, Xu J, Yang H, et al. HIF-1\u03b1-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Signal Transduct Target Ther. 2021;6:76.","journal-title":"Signal Transduct Target Ther"},{"key":"1821_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04672-5","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Dong D, Xia Y, Hao L, Wang W, Zhao C. YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance. Cell Death Dis. 2022;13:230.","journal-title":"Cell Death Dis"},{"key":"1821_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03129-9","volume":"23","author":"C Chen","year":"2023","unstructured":"Chen C, Zhai E, Liu Y, Qian Y, Zhao R, Ma Y, et al. ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer. Cancer Cell Int. 2023;23:293.","journal-title":"Cancer Cell Int"},{"key":"1821_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01575-z","volume":"21","author":"A Du","year":"2022","unstructured":"Du A, Li S, Zhou Y, Disoma C, Liao Y, Zhang Y, et al. m6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer. 2022;21:109.","journal-title":"Mol Cancer"},{"key":"1821_CR34","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/j.ymthe.2020.09.007","volume":"28","author":"X Liu","year":"2020","unstructured":"Liu X, Gonzalez G, Dai X, Miao W, Yuan J, Huang M, et al. Adenylate kinase 4 modulates the resistance of breast cancer cells to tamoxifen through an m6A-based epitranscriptomic mechanism. Mol Ther. 2020;28:2593\u2013604.","journal-title":"Mol Ther"},{"key":"1821_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/15476286.2020.1804697","volume":"18","author":"YJ Wang","year":"2021","unstructured":"Wang YJ, Yang B, Lai Q, Shi JF, Peng JY, Zhang Y, et al. Reprogramming of m6A epitranscriptome is crucial for shaping of transcriptome and proteome in response to hypoxia. RNA Biol. 2021;18:131\u201343.","journal-title":"RNA Biol"},{"key":"1821_CR36","doi-asserted-by":"crossref","first-page":"E2047","DOI":"10.1073\/pnas.1521518113","volume":"113","author":"C Zhang","year":"2016","unstructured":"Zhang C, Samanta D, Lu H, Bullen JW, Zhang H, Chen I, et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m\u2076A-demethylation of NANOG mRNA. Proc Natl Acad Sci USA. 2016;113:E2047\u201356.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1821_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"1821_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51634-w","volume":"15","author":"C Liu","year":"2024","unstructured":"Liu C, Dou X, Zhao Y, Zhang L, Zhang L, Dai Q, et al. IGF2BP3 promotes mRNA degradation through internal m7G modification. Nat Commun. 2024;15:7421.","journal-title":"Nat Commun"},{"key":"1821_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01771-5","volume":"22","author":"T Li","year":"2023","unstructured":"Li T, Gu Y, Xu B, Kuca K, Zhang J, Wu W. CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure. Mol Cancer. 2023;22:77.","journal-title":"Mol Cancer"},{"key":"1821_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216703","volume":"587","author":"ZY Yang","year":"2024","unstructured":"Yang ZY, Zhao C, Liu SL, Pan LJ, Zhu YD, Zhao JW, et al. NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3\/RBM14. Cancer Lett. 2024;587:216703.","journal-title":"Cancer Lett"},{"key":"1821_CR41","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.7150\/ijbs.80921","volume":"19","author":"L Yang","year":"2023","unstructured":"Yang L, Yan B, Qu L, Ren J, Li Q, Wang J, et al. IGF2BP3 regulates TMA7-mediated autophagy and cisplatin resistance in laryngeal cancer via m6A RNA methylation. Int J Biol Sci. 2023;19:1382\u2013400.","journal-title":"Int J Biol Sci"},{"key":"1821_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-024-03120-w","volume":"43","author":"B Wang","year":"2024","unstructured":"Wang B, Wang Y, Wang W, Wang Z, Zhang Y, Pan X, et al. WTAP\/IGF2BP3 mediated m6A modification of the EGR1\/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells. J Exp Clin Cancer Res. 2024;43:204.","journal-title":"J Exp Clin Cancer Res"},{"key":"1821_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","volume":"204","author":"EM Leslie","year":"2005","unstructured":"Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol. 2005;204:216\u201337.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1821_CR44","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","volume":"169","author":"KE Pendleton","year":"2017","unstructured":"Pendleton KE, Chen B, Liu K, Hunter OV, Xie Y, Tu BP, et al. The U6 snRNA m6A methyltransferase METTL16 regulates SAM synthetase intron retention. Cell. 2017;169:824\u201335.","journal-title":"Cell"},{"key":"1821_CR45","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1093\/nar\/gkaa227","volume":"48","author":"T Aoyama","year":"2020","unstructured":"Aoyama T, Yamashita S, Tomita K. Mechanistic insights into m6A modification of U6 snRNA by human METTL16. Nucleic Acids Res. 2020;48:5157\u201368.","journal-title":"Nucleic Acids Res"},{"key":"1821_CR46","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2147\/DDDT.S243420","volume":"14","author":"Y Liao","year":"2020","unstructured":"Liao Y, Tan RZ, Li JC, Liu TT, Zhong X, Yan Y, et al. Isoliquiritigenin attenuates UUO-induced renal inflammation and fibrosis by inhibiting Mincle\/Syk\/NF-kappa B signaling pathway. Drug Des Devel Ther. 2020;14:1455\u201368.","journal-title":"Drug Des Devel Ther"},{"key":"1821_CR47","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/antiox11071349","volume":"11","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Yung KK, Ko JK. Therapeutic intervention in cancer by isoliquiritigenin from licorice: a natural antioxidant and redox regulator. Antioxidants (Basel). 2022;11:1349.","journal-title":"Antioxidants (Basel)"},{"key":"1821_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155045","volume":"121","author":"M Yu","year":"2023","unstructured":"Yu M, Pan Q, Li W, Du T, Huang F, Wu H, et al. Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1\/PGC-1\u03b1 mediated energy metabolic collapse. Phytomedicine. 2023;121:155045.","journal-title":"Phytomedicine"},{"key":"1821_CR49","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1097\/CM9.0000000000002675","volume":"136","author":"Z Wang","year":"2023","unstructured":"Wang Z, Li W, Wang X, Zhu Q, Liu L, Qiu S, et al. Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells. Chin Med J. 2023;136:2210\u201320.","journal-title":"Chin Med J"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01821-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01821-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01821-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:04:34Z","timestamp":1787040274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01821-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1821"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01821-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}